Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon says that without trials there is no way pharmaceutical research can advance to improve... ...
http://pharma.financialexpress.com/sections/management/2146-need-to-take-a-pragmatic-view-of-clinical-trialsIn an affirmative sign, Ranbaxy shrugged off early losses after Monday's ruling to steadily climb 1.75 percent to Rs 463.45 on Wednesday on the... ...
http://www.firstpost.com/business/after-swallowing-bitter-pill-ranbaxy-set-to-revive-sales-to-us-787055.htmlce comes fromProject Syndicate. The opinions expressed are the author's own) The overwhelming victory of the Indian National Congress in elections... ...
http://blogs.reuters.com/india-expertzone/2013/05/15/the-resurrection-of-congress/?pfrom=home-reutersThe Indian bio-pharma industry is witnessing major challenges due to ongoing regulatory uncertainties and policy making based on knee jerk... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75319&sid=1Theyre argumentative, theyre aggressive, but what makes Indian leaders stand taller than their western counterparts is a different set of... ...
http://www.computerworld.in/opinion/indian-leaders-are-forcing-world-sit-and-take-notice-98702013